Enterprise value of Cue Biopharma (STU:1UC)

Cue Biopharma Company Value Chart

Cue Biopharma Annual Data
	trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	December 22	23rd of December
Enterprise value		Get a free 7-day trial				–	–	–	–	89.10

Competitive comparison of Cue Biopharma’s enterprise value

For the biotechnology Cue Biopharma’s enterprise value along with its competitors’ market capitalizations and enterprise value data can be viewed below:

* Competing companies are selected from companies in the same industry, headquartered in the same country and with similar market capitalization. The X-axis shows the market capitalization and the Y-axis shows the maturity value. The larger the dot, the higher the market capitalization. Note that “N/A” values ​​are not shown in the chart.

Cue Biopharma’s enterprise value distribution in the biotechnology industry

For the biotechnology Industry and Healthcare Sector: Cue Biopharma’s enterprise value distribution charts are below:

* The red bar shows where the enterprise value of Cue Biopharma lies.

Cue Biopharma company value calculation

Enterprise value is calculated as market capitalization plus debt, minority interests and preferred stock, less total cash, cash equivalents and marketable securities.

Cue Biopharma’s enterprise value for the Fiscal year that ended in December 2023 is calculated as

Cue Biopharma’s enterprise value for the quarter that ended in March 2024 is calculated as

* For the Operating Data section: All numbers are indicated by the unit following each term and all currency-related amounts are in USD.
* For other sections: All figures are in millions, except per share, ratio and percent amounts. All currency related amounts are stated in the Company’s respective exchange currency.

Explanation of the enterprise value of Cue Biopharma (STU:1UC)

When an investor buys a company, he must pay not only for the common stock, but also for the shareholders’ preferred stock. He also assumes the company’s debt and receives the cash on the company’s balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market capitalization because the money immediately belongs to him as soon as the transaction is completed.

The market value of Preference shares must be added to the market value of the common shares when calculating the enterprise value.

For companies with the same Market capitalizationthe smaller the company value, the cheaper the company is.

The company value can be negative if the company’s net cash flow is higher than its Market capitalizationIn this case, the investor essentially gets the company for free and is paid for it.

1. EV to EBIT is calculated as enterprise value divided by EBIT.

Keyword Biopharma EV to EBIT for Today Is

Cue Biopharma’s current Enterprise value is €17.27 million.
Keyword Biopharma EBIT for the last twelve months (TTM) to March 2024, the quarterly data reported by the company within the last 12 months are added, which amounted to -€44.99 million.

2. EV to EBITDA is calculated as enterprise value divided by EBITDA.

Keyword Biopharma EV to EBITDA for Today Is:

Cue Biopharma’s current Enterprise value is €17.27 million.
Keyword Biopharma EBITDA for the last twelve months (TTM) to March 2024, the quarterly data reported by the company within the last 12 months are added, which amounted to -€41.84 million.

3. EV-to-Sales is calculated as enterprise value divided by revenue.

Keyword Biopharma EV-to-Sales for Today Is:

Cue Biopharma’s current Enterprise value is €17.27 million.
Keyword Biopharma revenue for the last twelve months (TTM) to March 2024, the quarterly data reported by the company within the last 12 months are added, which amounted to €6.49 million.

* For the Operating Data section: All numbers are indicated by the unit following each term and all currency-related amounts are in USD.
* For other sections: All figures are in millions, except per share, ratio and percent amounts. All currency related amounts are stated in the Company’s respective exchange currency.

Keyword Biopharma Enterprise Value – Related Terms

Thank you for viewing the detailed overview of Cue Biopharma’s enterprise value by GuruFocus.com. Please click on the links below to view the pages with related terms.

Market capitalization

Preference shares

Long-term debt and leasing obligations

Cash, cash equivalents, marketable securities

Short-term debt and leasing obligations

Low interest

EV to EBIT

EV to EBITDA

EV-to-Sales

Cue Biopharma (STU:1UC) Business Description